Albuminuria: is it time to screen the general population?

Published

Journal Article (Review)

Albuminuria has been associated with increased risk of multiple adverse outcomes, including ESRD, acute kidney injury, cardiovascular disease, and death. Some clinicians advocate for population-based screening of this condition, as a means of identifying individuals at high risk for morbidity and mortality. Several factors influence the potential implementation of screening for albuminuria in the general population, including the type of test used, the threshold for albuminuria, the validity and prognostic value of testing, frequency of follow-up testing, and associated costs of screening. This review discusses the available literature addressing these issues, and suggests an approach to screening patients for albuminuria.

Full Text

Duke Authors

Cited Authors

  • Crews, DC; Boulware, LE; Gansevoort, RT; Jaar, BG

Published Date

  • July 2011

Published In

Volume / Issue

  • 18 / 4

Start / End Page

  • 249 - 257

PubMed ID

  • 21782131

Pubmed Central ID

  • 21782131

Electronic International Standard Serial Number (EISSN)

  • 1548-5609

Digital Object Identifier (DOI)

  • 10.1053/j.ackd.2011.06.004

Language

  • eng

Conference Location

  • United States